WASHINGTON -- The Biden administration purchased an additional 200 million doses of Pfizer-BioNTech's COVID-19 vaccine to prepare for potential additional vaccine needs in the US, an administration ...

Pfizer Inc. Chief Executive Albert Bourla had long searched for an obesity drug to make up for dwindling sales of the pharma company’s aging blockbusters. Late Friday, after a dramatic bidding war, he ...

Pfizer (NYSE:PFE) reported that its BRAFTOVI combination therapy produced significant progression free survival benefits in ...

Add Yahoo as a preferred source to see more of our stories on Google. Pfizer CEO Albert Bourla explains the deal his company has reached to offer some of its pharmaceuticals for less in the U.S. ©The ...

Shares of COVID-19 vaccine makers Pfizer Inc (NYSE:PFE), BioNTech SE ADR (NASDAQ:BNTX) and Moderna Inc (NASDAQ:MRNA) are trading lower Friday following a Washington Post report that Trump ...

Following reports that President Trump was launching a direct purchasing platform TrumpRx.gov and was going to announce a deal with Pfizer to lower drug prices, the president met with Pfizer CEO ...

Pfizer struck a deal with the Trump administration to lower its U.S. medicine prices and invest an additional $70 billion in onshore manufacturing in exchange for shelter from tariffs. Pfizer on ...